Table 2.
Conditions/complications | ASA II (n = 76) | ASA III (n = 91) | ASA IV (n = 31) | |||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Cutaneous ulcer | 7 | 7.7% | 6 | 19.4% | ||
Wound infection | 5 | 6.6% | 4 | 4.4% | 2 | 6.5% |
Pneumonia | 4 | 4.4% | 6 | 19.4% | ||
Pulmonary embolism | 2 | 2.2% | 5 | 16.1% | ||
Congestive heart failure | 5 | 5.5% | 4 | 12.9% | ||
Cerebrovascular accident | 3 | 3.3% | 2 | 6.5% | ||
Acute renal failure | 2 | 2.2% | 2 | 6.5% | ||
Ileus | 1 | 1.1% | 1 | 3.2% | ||
Myocardial infarction | 2 | 6.5% | ||||
Urinary infection | 4 | 5.3% | 3 | 3.3% | 5 | 16.1% |
Death | 3 | 9.7% | ||||
Total number of complications that occurred | 9 | 31 | 38 | |||
| ||||||
Comorbidities | ASA II (n = 76) | ASA III (n = 91) | ASA IV (n = 31) | |||
n | % | n | % | n | % | |
| ||||||
Hypertension | 51 | 67.1% | 76 | 83.5% | 30 | 96.8% |
Deficiency anaemia | 17 | 22.4% | 29 | 31.9% | 8 | 25.8% |
Fluid and electrolyte disorders | 18 | 23.7% | 31 | 34.1% | 12 | 38.7% |
Chronic pulmonary disease | 14 | 18.4% | 33 | 36.3% | 11 | 35.5% |
Diabetes mellitus | 7 | 9.2% | 8 | 8.8% | 7 | 22.6% |
Neurological disorders | 9 | 11.8% | 9 | 9.9% | 6 | 19.4% |
Thyroidism | 13 | 17.1% | 18 | 19.8% | 6 | 19.4% |
Congestive heart failure | 10 | 13.2% | 12 | 13.2% | 5 | 16.1% |
Depression | 5 | 6.6% | 9 | 9.9% | 4 | 12.9% |
Renal failure | 16 | 21.1% | 30 | 33.0% | 12 | 38.7% |
Peripheral vascular disorder | 12 | 15.8% | 17 | 18.7% | 16 | 51.6% |
Solid tumor | 0 | 0% | 1 | 1.1% | 1 | 3.2% |